SafeShield Antimicrobial Medical Waste Containers by Stericycle

Company to streamline medical waste collection with new portfolio of innovative containers to better serve customers and help protect communities

SafeShield antimicrobial medical waste containers, a line of high-quality, standardized containers, is specifically designed for the storage and transport of regulated medical waste (RMW).

Compared to Stericycle’s current containers, this new line of containers provides customers with an improved design, better storage options and an additional level of protection to help combat the growth of microorganisms on RMW containers. Stericycle previously began rolling out the containers to select U.S. markets and has planned a phased national rollout.

“Our SafeShield™ medical waste containers are designed to meet our customers’ needs as RMW generators,” commented Cory White, chief commercial officer at Stericycle. “The safe and efficient management of RMW helps hospitals and healthcare systems run more effectively. Through continued innovation and investment, Stericycle aims to provide safe, responsible and sustainable products and services that help healthcare organizations protect the health and well-being of the people and communities they serve, so they can focus on what matters most– patients.”

The new SafeShield™ containers include features such as:

  • Antimicrobial Properties: SafeShield™ containers are exclusively equipped with Cupron®, a copper-based antimicrobial additive to help prevent the growth of bacteria, fungi, mold and mildew, which can reduce odors and increase cleanliness. The containers also have a smooth interior finish with built-in drainage ports for easy cleaning.
  • Improved Design: These new, reusable RMW containers have an integrated lid that closes securely and eliminates lid misplacement. These containers are also nestable and stackable, enabling Stericycle drivers to load and transport more containers at one time.
  • Durability: SafeShield™ containers have reinforced handles to help withstand heavy loads. The split lid also securely locks and includes a tie area for added security during storage and transport.

Over the next several years, Stericycle will simplify its container portfolio and work with customers to transition from their current containers to the new models, ultimately aiming to reduce its line of more than 150 containers to less than 20. In 2021, approximately 75,000 new SafeShield™ containers were delivered to customers. In 2022, Stericycle plans to ship approximately 290,000 SafeShield™ containers to customers across the U.S. with an additional phased roll-out to follow. As the new containers are introduced in the marketplace, Stericycle will recycle as many of the decommissioned containers as possible to help reduce landfill waste.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version